[1]
Sara Zahid et al. 2024. CLINICAL SIGNIFICANCE OF DIFFERENTIAL EXPRESSION OF DIAGNOSTIC BIOMARKERS FOR THE DEVELOPMENT OF DIABETIC NEPHROPATHY. Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), 698–707. DOI:https://doi.org/10.53555/jptcp.v31i3.5016.